FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125408053> ?p ?o ?g. }

• W2125408053 endingPage "625" @default.
• W2125408053 startingPage "619" @default.
• W2125408053 abstract "<b>Background/aims:</b> Doxycycline is a broad spectrum antibiotic that chelates metal ions and is frequently used as part of the treatment of ocular surface diseases. Its therapeutic value has been ascribed to an ability to inhibit matrix metalloproteinase (MMP) activity and both MMP and IL-1 synthesis. The aim of this study was to evaluate the role of doxycycline as an inhibitor of corneal MMPs and assess its contribution to ocular surface repair mechanisms. <b>Methods:</b> Corneal epithelial cell and keratocyte cultures were grown to confluence and incubated with IL-1α, LPS, doxycycline, or doxycycline and LPS in serum free medium for 4 days. The cells were either harvested and assayed for caspase-3 activity or stained with either AE5 or antivimentin antibodies. Media samples were concentrated and assayed for MMP activity by zymography or using a fluorigenic substrate. ELISA was used to quantify IL-1α, MMPs -1,-2,-3,-9, and TIMPs -1 and -2. <b>Results:</b> IL-1α and LPS had no effect on MMP/TIMP production by cultured corneal epithelial cells and keratocytes. Corneal MMP-2 inhibition by doxycycline was partially [Ca²⁺] dependent but irreversible. At the minimum inhibitory concentration, 100 μm, doxycycline had no apparent effect on MMP and TIMP production, but ultimately caused the death of keratocytes and some of the epithelial cells that detached from their basement membrane. Caspase-3 activity was not detected in dead or dying keratocytes. The mechanism of cell death in cultured corneal epithelial cells was not caspase-3 related apoptosis as the activity of this enzyme, normally detectable, was lost. The epithelial cells that survived doxycycline treatment did not bind antivimentin antibody and compared with controls, reacted less with the AE5 antibody. They were probably transient amplifying cells. <b>Conclusions:</b> Doxycycline irreversibly inhibits corneal MMP-2 activity by chelating the metal ions that are catalytically and structurally essential. Corneal MMP/TIMP production in vitro is not modulated by IL-1α, LPS, or doxycycline. The therapeutic value of doxycycline may depend upon its effective concentration at the ocular surface and probably relates to its chelating properties." @default.
• W2125408053 created "2016-06-24" @default.
• W2125408053 creator A5067300324 @default.
• W2125408053 creator A5076375869 @default.
• W2125408053 date "2004-05-01" @default.
• W2125408053 modified "2023-10-14" @default.
• W2125408053 title "Doxycycline--a role in ocular surface repair" @default.
• W2125408053 cites W1503290529 @default.
• W2125408053 cites W1507844527 @default.
• W2125408053 cites W1523015364 @default.
• W2125408053 cites W1583304743 @default.
• W2125408053 cites W1600038678 @default.
• W2125408053 cites W1974705937 @default.
• W2125408053 cites W1985768272 @default.
• W2125408053 cites W1992101230 @default.
• W2125408053 cites W1995277420 @default.
• W2125408053 cites W2004101410 @default.
• W2125408053 cites W2008014733 @default.
• W2125408053 cites W2010587771 @default.
• W2125408053 cites W2016692114 @default.
• W2125408053 cites W2018289835 @default.
• W2125408053 cites W2038981906 @default.
• W2125408053 cites W2040320313 @default.
• W2125408053 cites W2050675069 @default.
• W2125408053 cites W2053692387 @default.
• W2125408053 cites W2056273618 @default.
• W2125408053 cites W2063936902 @default.
• W2125408053 cites W2072153975 @default.
• W2125408053 cites W2074206328 @default.
• W2125408053 cites W207753262 @default.
• W2125408053 cites W2084175887 @default.
• W2125408053 cites W2086421659 @default.
• W2125408053 cites W2100837269 @default.
• W2125408053 cites W2105042223 @default.
• W2125408053 cites W2113362104 @default.
• W2125408053 cites W2118340286 @default.
• W2125408053 cites W2119226652 @default.
• W2125408053 cites W2124552117 @default.
• W2125408053 cites W2130537267 @default.
• W2125408053 cites W2154610968 @default.
• W2125408053 cites W2155858736 @default.
• W2125408053 cites W2161867368 @default.
• W2125408053 cites W2164209124 @default.
• W2125408053 cites W2248431402 @default.
• W2125408053 cites W2411595593 @default.
• W2125408053 cites W88741246 @default.
• W2125408053 cites W1876378596 @default.
• W2125408053 doi "https://doi.org/10.1136/bjo.2003.025551" @default.
• W2125408053 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1772144" @default.
• W2125408053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15090411" @default.
• W2125408053 hasPublicationYear "2004" @default.
• W2125408053 type Work @default.
• W2125408053 sameAs 2125408053 @default.
• W2125408053 citedByCount "77" @default.
• W2125408053 countsByYear W21254080532012 @default.
• W2125408053 countsByYear W21254080532013 @default.
• W2125408053 countsByYear W21254080532014 @default.
• W2125408053 countsByYear W21254080532015 @default.
• W2125408053 countsByYear W21254080532016 @default.
• W2125408053 countsByYear W21254080532017 @default.
• W2125408053 countsByYear W21254080532018 @default.
• W2125408053 countsByYear W21254080532019 @default.
• W2125408053 countsByYear W21254080532020 @default.
• W2125408053 countsByYear W21254080532021 @default.
• W2125408053 countsByYear W21254080532022 @default.
• W2125408053 countsByYear W21254080532023 @default.
• W2125408053 crossrefType "journal-article" @default.
• W2125408053 hasAuthorship W2125408053A5067300324 @default.
• W2125408053 hasAuthorship W2125408053A5076375869 @default.
• W2125408053 hasBestOaLocation W21254080531 @default.
• W2125408053 hasConcept C109523444 @default.
• W2125408053 hasConcept C118487528 @default.
• W2125408053 hasConcept C126322002 @default.
• W2125408053 hasConcept C142724271 @default.
• W2125408053 hasConcept C153911025 @default.
• W2125408053 hasConcept C177430391 @default.
• W2125408053 hasConcept C190283241 @default.
• W2125408053 hasConcept C203014093 @default.
• W2125408053 hasConcept C2775958869 @default.
• W2125408053 hasConcept C2776193487 @default.
• W2125408053 hasConcept C2776882836 @default.
• W2125408053 hasConcept C2777179404 @default.
• W2125408053 hasConcept C2779257441 @default.
• W2125408053 hasConcept C31573885 @default.
• W2125408053 hasConcept C501593827 @default.
• W2125408053 hasConcept C54355233 @default.
• W2125408053 hasConcept C55493867 @default.
• W2125408053 hasConcept C71924100 @default.
• W2125408053 hasConcept C81885089 @default.
• W2125408053 hasConcept C86803240 @default.
• W2125408053 hasConcept C89423630 @default.
• W2125408053 hasConceptScore W2125408053C109523444 @default.
• W2125408053 hasConceptScore W2125408053C118487528 @default.
• W2125408053 hasConceptScore W2125408053C126322002 @default.
• W2125408053 hasConceptScore W2125408053C142724271 @default.
• W2125408053 hasConceptScore W2125408053C153911025 @default.
• W2125408053 hasConceptScore W2125408053C177430391 @default.
• W2125408053 hasConceptScore W2125408053C190283241 @default.

• next